Friday, July 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “rasagiline”

18 pharma patents match "rasagiline" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 18
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 18 pharmaceutical patents matching "rasagiline" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

18 results for “rasagiline” · 30,257 patents in full index Clear search

  1. US 12310929

    Use of rasagiline for the treatment of restless legs syndrome

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted May 27, 2025 · Expires May 22, 2045

    granted
  2. US 9308182

    Parenteral formulations of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 12, 2016 · Expires Apr 7, 2036

    granted
  3. US 8809310

    Use of rasagiline for the treatment of multiple system atrophy

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  4. US 8691872

    Dispersions of rasagiline citrate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 8, 2014 · Expires Apr 3, 2034

    granted
  5. US 8614252

    Crystalline solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 24, 2013 · Expires Dec 19, 2033

    granted
  6. US 8569379

    Use of rasagiline for the treatment of olfactory dysfunction

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 29, 2013 · Expires Oct 24, 2033

    granted
  7. US 8334409

    Process for purifying rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  8. US 8163960

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 24, 2012 · Expires Apr 19, 2032

    granted
  9. US 8080584

    Delayed release rasagiline citrate formulation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 20, 2011 · Expires Dec 15, 2031

    granted
  10. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 28, 2011 · Expires Jun 23, 2031

    granted
  11. US 7855233

    Citrate salt of Rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  12. US 7815942

    Rasagiline formulations of improved content uniformity

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 19, 2010 · Expires Oct 14, 2030

    granted
  13. US 7750051

    Crystalline solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 6, 2010 · Expires Jul 1, 2030

    granted
  14. US 7619117

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 17, 2009 · Expires Nov 12, 2029

    granted
  15. US 7598420

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 6, 2009 · Expires Oct 1, 2029

    granted
  16. US 7572834

    Rasagiline formulations and processes for their preparation

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Aug 11, 2009 · Expires Aug 6, 2029

    granted
  17. US 7547806

    Tannate salt of rasagiline

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 16, 2009 · Expires Jun 11, 2029

    granted
  18. US 7396860

    Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jul 8, 2008 · Expires Jul 3, 2028

    granted